Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nucleoside Derivatives - 7-Deazapurine nucleosides; Halo-nucleosides; Scaffolds and Templates
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | Inquiry | |
10 mg | 5 days | Inquiry | |
25 mg | 5 days | Inquiry | |
50 mg | 5 days | Inquiry | |
100 mg | 5 days | Inquiry | |
500 mg | 5 days | Inquiry |
Description | Nucleoside Derivatives - 7-Deazapurine nucleosides; Halo-nucleosides; Scaffolds and Templates |
Molecular Weight | 411.79 |
Formula | C17H18ClN3O7 |
CAS No. | 16754-79-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
6-Chloro-7-deaza-9-(2’,3’,5’-tri-O-acetyl-b-D-ribofuranosyl)purine 16754-79-3 inhibitor inhibit